NRC Health (NRC) stock
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/3075% above fair value
$25.16+0.17 (+0.68%)
Close on Nov 20, 2026Market cap $556.53MP/E –Yield 2.07%
NRC Health free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
NRC Health's free cash flow for the twelve months ending Jun 30, 2026 was $21.64M, up 133.4% year over year. For fiscal 2025 it was $15.74M, down 17.9% from the year before. Over ten years it grew -1.8% a year on average. The highest annual figure on record is $40.83M in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.74M | -17.9% |
| FY2024 | Dec 31, 2024 | $19.18M | -14.1% |
| FY2023 | Dec 31, 2023 | $22.33M | -15.5% |
| FY2022 | Dec 31, 2022 | $26.43M | -35.3% |
| FY2021 | Dec 31, 2021 | $40.83M | +11.4% |
| FY2020 | Dec 31, 2020 | $36.65M | +1.1% |
| FY2019 | Dec 31, 2019 | $36.26M | +7.0% |
| FY2018 | Dec 31, 2018 | $33.88M | +44.0% |
| FY2017 | Dec 31, 2017 | $23.52M | +2.9% |
| FY2016 | Dec 31, 2016 | $22.87M | +20.7% |
| FY2015 | Dec 31, 2015 | $18.95M | -20.1% |
| FY2014 | Dec 31, 2014 | $23.71M | +38.4% |
| FY2013 | Dec 31, 2013 | $17.13M | +2.0% |
| FY2012 | Dec 31, 2012 | $16.78M | +7.1% |
| FY2011 | Dec 31, 2011 | $15.67M | +19.9% |
| FY2010 | Dec 31, 2010 | $13.06M | +21.4% |
| FY2009 | Dec 31, 2009 | $10.76M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $62.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $5.35M | +46.1% |
| Q4 FY2025 | Dec 31, 2025 | $6.06M | +213.1% |
| Q3 FY2025 | Sep 30, 2025 | $10.18M | +30.0% |
| Q2 FY2025 | Jun 30, 2025 | -$4.15M | -373.5% |
| Q1 FY2025 | Mar 31, 2025 | $3.66M | -53.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.94M | -75.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.83M | +46.4% |
| Q2 FY2024 | Jun 30, 2024 | $1.52M | -66.3% |
| Q1 FY2024 | Mar 31, 2024 | $7.90M | +73.5% |
| Q4 FY2023 | Dec 31, 2023 | $7.94M | +29.3% |
| Q3 FY2023 | Sep 30, 2023 | $5.35M | -11.9% |
| Q2 FY2023 | Jun 30, 2023 | $4.50M | -47.0% |
| Q1 FY2023 | Mar 31, 2023 | $4.55M | -20.8% |
| Q4 FY2022 | Dec 31, 2022 | $6.14M | -40.7% |
| Q3 FY2022 | Sep 30, 2022 | $6.07M | -21.3% |
| Q2 FY2022 | Jun 30, 2022 | $8.48M | -11.6% |
| Q1 FY2022 | Mar 31, 2022 | $5.75M | -56.4% |
| Q4 FY2021 | Dec 31, 2021 | $10.36M | -29.4% |
| Q3 FY2021 | Sep 30, 2021 | $7.71M | -18.9% |
| Q2 FY2021 | Jun 30, 2021 | $9.59M | +27.2% |
| Q1 FY2021 | Mar 31, 2021 | $13.17M | +167.0% |
| Q4 FY2020 | Dec 31, 2020 | $14.67M | +36.9% |
| Q3 FY2020 | Sep 30, 2020 | $9.51M | -18.9% |
| Q2 FY2020 | Jun 30, 2020 | $7.54M | -1.5% |
| Q1 FY2020 | Mar 31, 2020 | $4.93M | -20.0% |
| Q4 FY2019 | Dec 31, 2019 | $10.72M | -16.3% |
| Q3 FY2019 | Sep 30, 2019 | $11.72M | +114.6% |
| Q2 FY2019 | Jun 30, 2019 | $7.66M | -11.8% |
| Q1 FY2019 | Mar 31, 2019 | $6.17M | -11.0% |
| Q4 FY2018 | Dec 31, 2018 | $12.80M | +137.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.46M | -44.9% |
| Q2 FY2018 | Jun 30, 2018 | $8.69M | +474.6% |
| Q1 FY2018 | Mar 31, 2018 | $6.93M | +3.2% |
| Q4 FY2017 | Dec 31, 2017 | $5.39M | -31.9% |
| Q3 FY2017 | Sep 30, 2017 | $9.90M | +66.6% |
| Q2 FY2017 | Jun 30, 2017 | $1.51M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.72M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.92M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.95M | – |
See a number that looks wrong?